Adaptive Biotechnologies Launches T-Detect™ COVID, First Clinical T-Cell Based Test for Patients to Confirm Recent or Prior COVID-19 Infection

    NEXT STORY
    Black Diamond Therapeutics to Present at Upcoming Investor Conferences
    PREV STORY
    Outlook on the Cephalosporin Global Market to 2026 – Players Include Allergan, GlaxoSmithKline and Lupin Among Others
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Affimed Announces Pipeline and Business Update

    author_avatar
    NASDAQ Market News

    Chinook Therapeutics Announces Upcoming Data Presentations and Investor Conference Call During the American Society of Nephrology (ASN) Kidney Week 2020 Reimagined

    author_avatar
    NASDAQ Market News

    Cempra Reports First Quarter 2017 Financial Results and Provides Corporate Update

    CHAPEL HILL, N.C., April 28, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage ...

    author_avatar
    NASDAQ Market News